Skip to main content

GOLDMAN SACHS GROUP INC

Position in CGC — Canopy Growth Corp

CIK 886982 NEW YORK, NY

Position in CGC

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,199,158
+$309,552 QoQ
Shares Held
1,263,602
+61.9% QoQ
Ownership
0.299%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CGC Over Time

Shares Held

Position Value (USD)

Derivatives in CGC

reported options exposure · as of Mar 31, 2024
CallValue
$0
CallShares
0
PutValue
$338,296
PutShares
39,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $1,741,757,397 across 53 Drug Manufacturers - Specialty & Generic names. CGC ranks #44 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CGC

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,199,158 1,263,602
2025-12-31 $889,606 780,357
2025-09-30 $1,569,068 1,074,705
2025-06-30 $1,242,782 1,018,674
2025-03-31 $300,552 330,278
2024-12-31 $549,802 200,658
2024-09-30 $954,287 197,985
2024-06-30 $851,651 132,039
2024-03-31 $338,296 39,200
2024-03-31 $2,133,430 247,211
2023-12-31 $283,068 55,395